Dermatology Trials
-
31/03/2022
SOLAR: A Phase 2 Randomized Open-label Parallel-group Active Comparator Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects with Cutaneous T-Cell Lymphoma (CTCL) Mycosis Fungoides (MF) Subtype
View Trial -
30/04/2022
PARCT
Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IV mycosis fungoides/sezary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)
View Trial -
01/08/2023
Investigating the immune response to haematological malignancies with a view to novel therapies
View Trial -
01/12/2019
RESMAIN
A multicentre double blind randomised placebo-controlled Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy the RESMAIN Study
View Trial -
30/08/2015
035 Continuation study
An open-label treatment-option protocol of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma systemic anaplastic large cell lymphoma or CD30-positive cutaneous T-cell lymphoma
View Trial -
21/07/2030
PROCLIPI
Multicenter Observational Prospective Study for the Identification of Prognostic Factors in Patients With Mycosis Fungoides/sezary Syndrome: Proposal for An International Prognostic Index for Cutaneous Lymphoma
View Trial -
31/03/2027
Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: A randomized phase III trial of the EORTC Melanoma Group
View Trial -
31/05/2021
EczTend
Long-term extension trial in subjects with atopic dermatitis who participated in previous tralokinumab trials ECZTEND
View Trial -
31/03/2021
Phase 4 Placebo Controlled Study of the Impact of Apremilast on Quality of Life Efficacy and Safety in Subjects with Manifestations of Plaque Psoriasis and Impaired Quality of Life
View Trial